Vitreous fluid specimens are often used in the Montgomery County Coroner's Office as a second matrix confirmation for both cocaine and opiate analyses. In this manuscript, calibration curves constructed for both vitreous and blood were used to quantify vitreous specimens to evaluate if any matrix effects occur when measuring vitreous specimens using a calibration curve in blood. Cases that screened positive by ELISA for cocaine metabolite and opiates were confirmed by solid-phase extraction. Gas chromatography with mass spectral detection in the positive electron impact mode was used for the detection and quantification of oxycodone, free morphine, codeine, 6-monoacetylmorphine, hydrocodone, cocaine, and benzoylecgonine. For interpretive purposes, no significant matrix effects were found in concentrations of vitreous specimens quantified with a calibration curve constructed in a blood matrix. After determining that vitreous fluid can be accurately measured with blood calibrators, a comparison was made between blood and vitreous concentrations for the above analytes. Concentration differences between blood and vitreous specimens for each drug are evaluated with selected case histories included.
Introduction
Vitreous fluid has proven to be the specimen of choice for the Montgomery County Coroner's Office (MCCO) as a second matrix for confirmation of positive opiate or cocaine metabolite immunoassay screens. The eye is composed of 80% vitreous humor, which is 99% water with the remaining 1% made up of sugars, salts, phagocytes, and a network of collagen fibers (1) . Diffusion has been cited as the method of transport from systemic circulation to the vitreous humor. Esterases are lacking from vitreous humor, which could add to the sta-* Author to whom correspondence should be addressed: E-mail: antonidesh@mcohio.org.
bility of opiates and cocaine in this matrix. Vitreous fluid specimens are preferred in this laboratory because of an apparent delay in distribution, and therefore peak concentration, of 6-monoacetylmorphine (6-MAM) and also for its cleanliness as compared to other matrices, such as liver or urine. When available, vitreous humor is collected with every case during autopsy for toxicological analysis.
Matrix effects for alternative matrices are not assessed at many laboratories because of heavy case loads and large batch runs. Only one set of matrix calibrators are run routinely; for this reason only blood calibrators are used. If possible, matrix matched calibrators are recommended by the American Board of Forensic Toxicology and the American Academy of Forensic Science Laboratory Guidelines when dealing with vitreous specimens (2) . The question then arose as to whether there was a significant matrix effect if quantification of vitreous fluid was performed using calibrators prepared in a blood matrix. Therefore, a comparison was made between the measurement of vitreous fluid using a calibration curve prepared from blood matrix and a calibration curve prepared from vitreous matrix.
Opiate and cocaine metabolite immunoassay kits for vitreous specimens were evaluated using both blood and vitreous low positive, positive, and negative controls. Screening resuits for all vitreous specimens and contro]s were consistent with the corresponding blood data. Vitreous specimens that screened positive for either opiates or cocaine metabolite by immunoassay based on the positive control were then confirmed with solid-phase extraction (SPE). The extracted specimens were derivatized with N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) + 1% TMCS and then analyzed by gas chromatography-mass spectrometry (GC-MS) in the positive electron impact mode using selected ion monitoring (SIM) for opiates and the SCAN mode for cocaine analysis.
Linear regression graphs were used to evaluate blood and vitreous calibrator responses over several batch runs. Fifteen cases were analyzed for both opiates and cocaine for the purpose of comparing vitreous specimens quantified by both blood and vitreous calibration curves. For interpretive purposes, the variability in concentration for the analytes was not significant. In addition, 40 cocaine cases and 52 opiate cases were analyzed by comparing the blood and vitreous concentrations in an attempt to establish a correlation between values. When available, case histories were reviewed to provide further insight into any correlations.
testing. Vitreous specimens from cases that were determined to have no detectable amount of cocaine, cocaine metabolites, or opiates and were free of blood contamination were combined for the blank vitreous matrix. During routine autopsies, blood samples were collected in grey-top tubes containing sodium fluoride and potassium oxalate. Vitreous samples were collected in red-top tubes which contain no preservatives. All samples were stored at 4~ until analysis.
Vitreous specimens were screened for opiates and cocaine metabolite by immunoassay kits used with the Tecan Miniprep 75 automated system. Both blood and vitreous positive controls were prepared by spiking blank synthetic blood and vitreous matrices with morphine and BE for final concentrations of 0.05 IJg/mL and 0.10 IJg/mL, respectively. A low positive control was used for opiates with a final concentration of 0.025 IJg/mL of morphine. All results greater than the positive control were confirmed for BE for both blood and vitreous specimens. In order to detect positive oxycodone cases, results greater than the opiate low positive control were confirmed for opiates for both blood and vitreous specimens.
For opiate quantification, 50 IJL of 10 IJg/mL morphine-d3, codeine-d3, hydrocodone-d3, and oxycodone-d3 internal standard was added to 2 mL of all specimens. Specimens were sonicated for 15 rain; 14 mL of 0.1M, pH 6.0 phosphate buffer was added, and specimens were rotated for 5 rain. After centrifugation, specimens were applied to SPE columns preconditioned with methanol and phosphate buffer. The SPE columns were washed using 0.01M acetic acid and 1:1 acetone/chloroform; specimens were eluted with 4% ammonium hydroxide in ethyl acetate. Eluents were evaporated to dryness and reconstituted with 50 IJL BSTFA + 1% TMCS and 50 IJL ethyl acetate for derivatization at 75~ for 45 rain (3) (4) (5) . Specimens were analyzed for opiates using an Agilent GC-MS with DB-5 MS capillary column (30 m • 0.25-ram i.d., 0.25-1Jm film thickness). The temperature program was 80~ ramped to 170~ at 40~ then ramped to 290~ at 10~ and held for 3.75 rain. The injection volume was 2.0 IJL in splitless mode with an inlet temperature of 250~ The detector temperature was maintained at 310~ The following ions were monitored for the opiate analysis: 399.2, 6-MAM; 429.3, morphine; 432.35, morphine-d3; 371.2, hydrocodone and codeine; 374.2, hydrocodone-d3 and codeine-d3; 459.3 and 444.2, oxycodone; and 462.3, oxycodone-d3. Morphine-d3 was used to quantify 6-MAM, and the 444.2 ion was used as the qualifier for oxycodone in order to calculate ion ratios. All other analytes were confirmed by detection in at least two matrices and by a positive immunoassay result. Hydromorphone can also be quantified by this method; however, no positive cases were detected.
Quantification for all opiates was based on a four-point calibration curve using the following concentrations: 0.02, 0.07, 0.33, and 0.50 IJg/mL. Blood and vitreous calibrators were run in duplicate only during the evaluation for matrix effects. Both vitreous and blood calibrators and blanks were run with each batch of specimens along with high and low blood controls. Only blood controls were analyzed because of the lack of a second source for the analytes to spike into a blank vitreous specimen. The purchased blood control was within + 20% or • 2 standard deviations (SD) for both vitreous and blood calibrators. Between-run CV results were 12%, 6-MAM; 11%, free morphine; 9%, codeine; 6%, hydrocodone; and 5%, oxycodone for the low control and 11%, 6%, 7%, 11%, and 4% for the high control, respectively. Within-run CV results were 10%, 6-MAM; 2%, free morphine; 3%, codeine; 3%, hydrocodone; and 3%, oxycodone for the low control and 11%, 1%, 1%, 1%, and 2% for the high control, respectively. Both the limit of detection (LOD) and quantification (LOQ) for this method were determined by the low calibrator. The upper limit of linearity was determined by a linearity study to be 1.0 lJg/mL for all analytes.
For cocaine analysis, 50 IJL of both 10 3 IJg/mL cocaine-d3 and 20 lag/mL of ben- 2.5 zoylecgonine-d8 internal standard was added to 2 mL of the specimen. Blood and vitreous ; 2 specimens treated with 4 mL 5% zinc sulfate "= 1.5 precipitating solution in distilled v~ water/methanol (7:3) were vortex mixed and ~ 1 centrifuged before applying to the SPE 0.5 columns. Columns were preconditioned with o methanol, distilled water, and sodium acetate buffer. After the specimens were added to the SPE columns, the columns were washed with distilled water, 0.1M hydrochloric acid, and methanol. The specimens were eluted with methylene chloride/2-propanol/ammonium hydroxide (78:20:2), evaporated to dryness, and reconstituted with BSTFA + 1% TMCS for derivatization at 70~ for 20 rain (3,7).
2.5 The specimens were injected onto the hgilent ~ 2 GC-MS with a DB-5MS capillary column (30 ! 1.5 m x 0.25-ram i.d., 0.25-1Jm film thickness). " The temperature program was 80~ ramped 1 to 170~ at 40~ held for 2.0 rain, then 0.5 ramped to 290~ at 10~ and held for o 2.0 min. The injection volume was 1.0 IJL in splitless mode with an injector temperature of 250~ The detector temperature was maintained at 310~ In full scan mode, the following ions were monitored for the cocaine analysis (asterisks denote quantifying ions): 303", 198, 182 for cocaine; 361', 240, 256 for BE; 306 for cocaine-d3; and 369 for BE-ds. Area ratios were calculated for cocaine and 3 BE using the qualifying ions. Ecgonine 2.5 methyl ester was also detected but not quan-.~ 2 tiffed. Cocaethylene can also be quantified by this method; however, no positive cases were .~ 1.5 detected.
~ 1 Cocaine analysis calibration concentrations ~ 0.5 were 0.05, 0.1, 0.5, and 2.5 IJg/mL and 0.1, 0.2, 1.0, and 5.0 IJg/mL for cocaine and o BE, respectively. Blood and vitreous calibrao tors were run in duplicate only during the evaluation for matrix effects. Positive low and high blood controls, vitreous and blood blanks, and both matrix calibrators were included with each batch of cases. Again, only the purchased blood control was run for quality control. The control was in the acceptable range using both the vitreous and blood calibrators. The between-run CV values for cocaine low and high controls were 6.5% and 7.4%, respectively. Cocaine within-run CV values were 2.1% and 5.2% for the low and high controls, respectively. BE CV between-run values were 11% and 8% for the low and high controls, respectively. The within-run CV values for BE were 2.7% and 3.6% for the low and high controls, respectively. Both the LOD and LOQ were based on the low calibrator for this assay. The upper limit of linearity was determined by the high calibrator.
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Results and Discussion
Immunoassay results for all opiates, except oxycodone, were consistent with confirmation results for both blood and vitreous controls and cases. When the concentration of oxy-
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Blood Calib. 5 .v = 9.7428x + 0.0267 codone was greater than 0.10 t~g/mL, immunoassay results for oxycodone screened positive in both blood and vitreous positive specimens based on the ELISA opiate positive control. In cases where the oxycodone concentration was less than 0.10 IJg/mL, all specimens screened positive by immunoassay based on the ELISA low positive opiate control. This could result from the lower cross reactivity for oxycodone using the opiate ELISA kit. Approximately 0.120 IJg/mL of oxycodone is listed by the package insert as equivalent to 0.025 IJg/mL of morphine, the target analyte. Therefore, the low positive control was used to determine positive opiate cases. For cocaine immunoassay results, 100% of cases and controls screened positive in both matrices. As BE is the target analyte for this immunoassay kit, these results were expected, and BE was confirmed in all specimens where a positive immunoassay result occurred. Calibration curves for both opiate and cocaine analysis were constructed using Microsoft Excel software for both blood and vitreous calibrators by analyzing four different o.s calibrator concentrations over several batch runs. A total of five batch runs containing duplicate measurements for each calibration concentration point on the respective curve were analyzed. An average of the relative areas for each calibrator was plotted against the target concentration in Figures 1-6 . Correlation coefficients (R 2) were calculated to evaluate the linearity of each curve. A correlation coefficient of 0.99 is commonly accepted. To further assess the matrix effects for each analyte, vitreous case specimens were calculated using both blood and vitreous calibration curves. Vitreous case concentrations of opiates and cocaine are listed in Tables I and II,  respectively. Any discrepancies that occurred  3 between vitreous values were not more than 20% of their average, which is the acceptable precision range. In the instances where concentrations were out of the acceptable range, multiple analyses were limited by the volume of vitreous fluid provided to the toxicology section. Given an increased vitreous specimen volume, multiple analyses could have been performed and these discrepancies would have been further evaluated. Overall, the data in Tables I and II support the absence of matrix effects when quantifying vitreous specimens using a blood or vitreous calibration curve. Calibration curves for morphine and oxycodone are shown in Figures 1 and 2 , respectively. Minimal matrix effects are 3 demonstrated by both analytes over the concentration range of the curve as established by both figures and the data comparison of Table  I . Differences in measurement of vitreous fluid using the vitreous and blood calibration curves Fi gure 5. Comparison of vitreous and blood calibration curves for cocaine. were negligible when the concentration was compared to the normal variability seen with the positive controls. Therefore, both oxycodone and morphine vitreous concentrations were comparable using the blood and vitreous calibration curves. Codeine and 6-MAM show increased matrix effects between the two specimen types as demonstrated by Figures 3 and 4 . Discrepancies occur both at the low and high end of the curve for 6-MAM; however, Table I shows the results were still comparable. A discrepancy was also seen for codeine at the high end of the curve, but it was negligible based on the results in Table  I . The hydrocodone calibration curve was similar to that of codeine, in that a discrepancy occurred at the higher end of the curve. Data was provided in Table I to illustrate that these differences were insignificant for this analyte as well.
Cocaine and BE calibration data are presented in Figures 5 and 6 Tables IlI and IV. After reviewing several publications regarding vitreous versus blood specimen concentrations for opiates and cocaine, it was noted that case histories are usually not provided. In this manuscript, individual case histories and concentrations for both specimens were utilized when available to evaluate the resuits with respect to interpretive value.
Cocaine concentrations were higher in vitreous fluid in 72% of the cases reviewed where cocaine was detected in one or both matrices. After reviewing case histories, blood concentrations of cocaine were higher in cases where acute intoxication was apparent. Postmortem intervals for these cases were short as the deaths were witnessed and reported promptly. For example, in cases 17 and 27 in Table IV, the decedents had both swallowed cocaine while running from the police. In cases 7 and 24, the decedents had long histories of drug abuse; however, according to witnesses, they became unconscious or had seizures upon acute ingestion of cocaine. Benzoylecgonine was higher in blood 78% more often than in vitreous. In these cases where cocaine was higher in blood than vitreous, BE was significantly higher in the blood by as much as 10-fold. The pH of all vitreous specimens was determined before analysis and found to be approximately 7. Therefore, hydrolysis of cocaine to BE could account for some of the BE in the vitreous matrix (6,7). Cocaine and BE data suggest that these two analytes have slower distribution into the vitreous. These results were similar to other publications where blood and vitreous specimens were analyzed for cocaine and BE (8, 9) . Acute intoxications were characterized by the concentrations of cocaine and BE being much higher in blood than in vitreous fluid.
Opiate concentrations for both blood and vitreous specimens, along with case histories were also reviewed. However, distinguishing acute versus chronic use based on case histories was not as clear as with cocaine and BE data. In all cases positive for 6-MAM, vitreous concentrations were higher than blood concentrations regardless of postmortem intervals. In case histories where heroin was mentioned, postmortem in- and Vit Cal, vitreous calibration tervals ranged from hours to days. Oxycodone and hydrocodone had higher concentrations in vitreous than blood in 96% and 71% of cases, respectively. After all results were compiled for this manuscript, two additional cases of interest were analyzed. Cases 51 and 52 were positive for oxycodone, but the re- ]n cases where morphine was present in con-0.23 junction with 6-MAM, morphine was higher in < 0.02 blood in 71% of the cases. Case 17 in Table Ill  0.15 was an example of an acute overdose. The ND 0.15 decedent injected heroin and was found not 0.28 breathing approximately 40 min later. In this ND case, morphine was present in the blood, but ND not detected in the vitreous. The 6-MAM re-0.04 suits for this case were 0.08 pg/mL in the vit-ND reous specimen and not detected in the blood 0.05 specimen. The remaining 29% of cases showed 0.44 an equal distribution of values for morphine < o.o2
concentrations between blood and vitreous o.33 specimens. Results for codeine, where 6-MAM o.o2 and morphine were also present, showed 64% 0.03 0.04 of these cases had codeine concentrations 0.15 equal in both matrices. However, case 10 was 0. 13 an example of one blood codeine concentrao.o8 tion that was significantly higher than the vit-0.12 reous codeine concentration; in this case, the < 0.02 decedent had been injecting heroin for sev-0.05 eral hours prior to death. It should be noted 0.o4 that the blood morphine concentration in this 0.27 case was almost four times greater than that in o.o3 vitreous. The 6-MAM results for this case were ND 0.27 pg/mL for the vitreous and 0.05 pg/mL 0.10 0.47 for the blood. In cases where morphine was 0.77 present alone or in conjunction with an opiate other than 6-MAM, the concentrations were evenly distributed between blood and vitreous specimens. Only three cases were positive for codeine where 6-MAM was not also present. In these cases, vitreous concentrations were higher than the blood concentrations regardless of the presence of morphine.
For the opiate class, the data suggest that there was slower distribution of drug into the vitreous which results in a longer time to reach maximum concentration (10) . This was most apparent with 6-MAM, which was present either only in the vitreous or in a higher concentration in the vitreous specimens. This observation was also consistent with other studies where 6-MAM was measured in vitreous and blood specimens (11) (12) (13) . The morphine concentrations in this study and the previously published studies were greater in the blood specimen in the majority of the cases where 6-MAM was present (11) (12) (13) . Oxycodone also exhibited slower distribution to the vitreous based on the review of the case histories where two acute overdoses had higher blood concentrations compared to the vitreous concentrations. Although hydrocodone was detected in several cases, many of the quantifications that were higher in the vitreous specimens were so by only negligible amounts. The case histories provided little information for interpreting acute hydrocodone intoxication. The codeine concentrations in these cases were difficult to interpret because of the few cases that were available specifically for codeine analysis and based on the knowledge that codeine is an impurity frequently encountered in heroin samples (14) . 
Conclusions
Both vitreous and blood controls and specimens from cases produced consistent results in the immunoassay screens for benzoylecgonine and opiates. The data comparing vitreous and blood calibrators demonstrated that matrix effects in these analyses were minimal. Therefore, measuring vitreous specimens with blood calibrators was acceptable. Any variability that occurred did not differ from the normal variability that occurs with positive blood controls that are run with each batch, except for those cases where sufficient amount of vitreous fluid specimen was not available.
A relationship between vitreous and blood concentration is not established for most drugs including opiates, cocaine, and cocaine rnetabolite. Data have been provided showing concentrations for both specimens in cases analyzed at MCCO. Oxycodone, hydrocodone, and 6-MAM had higher concentrations in the vitreous fluid than in blood in 96%, 71%, and 100% of the cases, respectively. Morphine and codeine concentrations had greater variance between blood and vitreous specimens in comparison with other opiates, depending on the source of the drug. For cocaine, concentrations in vitreous specimens were higher than the blood in 72% of the cases analyzed. Blood specimens showed higher concentrations of BE than in the vitreous specimens in 78% of the cases analyzed.
Acute overdoses were easier to identify in the cocaine cases based on the information provided in the case history along with the blood and vitreous concentrations. The findings suggested that cocaine and BE distribute more slowly into the vitreous fluid because, in cases of acute overdose, values of each analyte were higher in the blood as compared to the vitreous specimen. Because of different half-lives and dosing intervals within the opiate class, it was often unclear if exposure was acute, chronic, or acute toxicity in addition to chronic use. However, the data were still useful in identifying the use of heroin because of the prolonged detection of 6-MAM in vitreous specimens. Interestingly, many of the oxycodone cases analyzed had much higher vitreous concentrations than blood concentrations where chronic abuse was noted in the case history. The availability and common use of a time released preparation of oxycodone could be a contributing factor in this observation. Analysis of vitreous specimens offers an extended window of drug detection for those drugs with shorter halflives, specifically cocaine and 6-MAM. In several instances both of these analytes were detected in vitreous and not detected in the blood matrix. Lastly, oxycodone, hydrocodone, 6-MAM, cocaine, and BE were detected in higher concentrations in the majority of the cases reported, suggesting that detection is possible for a longer period in the vitreous sample.
